Pharmacological chaperones for enzyme enhancement therapy in genetic diseases.
about
Emerging novel concept of chaperone therapies for protein misfolding diseasesGene therapy for lysosomal storage disorders: a good start.Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG.Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease.Protein misfolding diseases: prospects of pharmacological treatment.Taming molecular flexibility to tackle rare diseases.New insights into the pharmacological chaperone activity of c2-substituted glucoimidazoles for the treatment of Gaucher disease.
P2860
Q27002907-CE4C4BF0-5A07-4253-847F-D12B0049AFE8Q34502978-0B6BA0C2-6451-476A-8CD9-ACC67279CF42Q36172720-5ED1C0BE-AEA2-43CB-A5C8-C325B01A1D77Q39038494-64969191-E5CA-4EFC-A1AE-0B0972BC3E60Q39410882-78E4FDAC-6FC6-4B5F-95AE-7D39B1919AB8Q40960071-B9420BA6-8FFF-4A83-BE43-334DD0C03209Q45931929-AE9EED52-FC25-4239-9F1B-E020972756D3
P2860
Pharmacological chaperones for enzyme enhancement therapy in genetic diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological chaperones for enzyme enhancement therapy in genetic diseases.
@en
type
label
Pharmacological chaperones for enzyme enhancement therapy in genetic diseases.
@en
prefLabel
Pharmacological chaperones for enzyme enhancement therapy in genetic diseases.
@en
P2093
P2860
P356
P1476
Pharmacological chaperones for enzyme enhancement therapy in genetic diseases
@en
P2093
Juan Aymami
Laura Rodríguez-Pascau
Marc Martinell
P2860
P304
P356
10.4155/PPA.12.74
P577
2013-01-01T00:00:00Z